Cavu Advisors, LLC, Director, 10% Owner at IN8BIO, INC. (INAB), bought 81,642 shares at $2.02 ($165K) on 2022-08-29, disclosed to the SEC on 2022-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 1,306 | $3K | 1.6% |
| 2 | $2.01 | 1,377 | $3K | 1.7% |
| 3 | $2.01 | 8,531 | $17K | 10.4% |
| 4 | $2.02 | 4,660 | $9K | 5.7% |
| 5 | $2.02 | 4,912 | $10K | 6.0% |
| 6 | $2.02 | 30,428 |
| $61K |
| 37.3% |
| 7 | $2.02 | 30,428 | $61K | 37.3% |
| Total | $2.02 avg | 81,642 | $165K | 100% |
| Filing → |
| LTRN | SELL | 2024-05-28 | $277K | — | Filing → |
| AZTR | BUY | 2023-06-23 | $3.0M | — | Filing → |